Advocacy intelligence hub — real-time data for patient organizations
Monument Therapeutics Limited — PHASE1, PHASE2
SpringWorks Therapeutics, Inc. — PHASE1
University of California, San Francisco — NA
Optinose US Inc. — PHASE3
Evi Liliek Wulandari — PHASE4
Azidus Brasil — PHASE3
Santen SAS — PHASE3
Interna Therapeutics Ltd. — PHASE1
DermBiont, Inc. — PHASE2
Science Valley Research Institute — PHASE4
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Elias Jabbour, MD, M.D
M.D. Anderson Cancer Center
📍 HOUSTON, TX
David Rosmarin, MD, M.D
Dermatology
📍 BELMONT, MA
Use Central Contact
Astellas Pharma Inc
ICD CSD
Sanofi
Moshe Phillip, Professor
Schneider Children Medical Center
Adam L. Boxer, M.D., Ph.D., M.D
UCSF Memory and Aging Center
📍 SAN FRANCISCO, CA